• Acetylcholine is a major neurotransmitter in the brain1
  • In patients with AD, cholinergic neurons are progressively lost, reducing levels of acetylcholine1
  • ChEIs target cholinesterase enzymes (AChE and BuChE) and inhibit the breakdown of acetylcholine.1-3This increases the availability of acetylcholine at the cholinergic synapses.1,2
  • Currently available FDA-approved ChEIs for the treatment of mild, moderate and severe AD are donepezil, rivastigmine, and galantamine1

Acess our Slide Deck on Treatment principles of Alzheimer’s disease (AD) and learn more about treatment with cholinesterase inhibitors.

file_download Download in HQ

Related content

image Image The pathology of ischaemic stroke is complex, but commonly involves the formation of a clot that travels in the blood to or within the brain and becomes lodged in the blood vessels of the brain (a thromboembolism), which can reduce or block blood flow (an occlusion).
Pathology of Ischaemic Stroke

The pathology of ischaemic stroke is complex, but commonly involves the formation of a clot that travels in the blood to or within the brain and becomes lodged in the blood vessels of the brain (a thromboembolism), which can reduce or block blood flow (an occlusion).

22.04.2024 Neurobehavioral Consequences of Stroke
image Image Post-stroke neuropsychiatric symptoms (NPS) - Fatigue
Post-stroke Neuropsychiatric Symptoms (NPS) – Fatigue

Post-stroke fatigue is an under-recognized NPS, which healthcare professionals should anticipate in patients.

22.04.2024 Neurobehavioral Consequences of Stroke
image Image Brain circuitry and emotional lability
Brain Circuitry and Emotional Lability

Emotional lability describes episodes of involuntary and uncontrollable crying and/or laughing, outside of socially appropriate circumstances and when it is incongruent with the patient’s emotional state.

22.04.2024 Neurobehavioral Consequences of Stroke